ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Active Transdermal Drug Delivery Device Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-20K9407
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Active Transdermal Drug Delivery Device Market Insights and Forecast to 2028
BUY CHAPTERS

Global Active Transdermal Drug Delivery Device Market Research Report 2025

Code: QYRE-Auto-20K9407
Report
August 2025
Pages:96
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Novartis
Noven Pharmaceuticals, Inc.
Transdermal Corp.
Johnson& Johnson (Janssen Pharmaceuticals Inc.)
Mylan N.V.
3M
Actavis
Bayer
Boehringer Ingelheim GmbH
Corium International, Inc.
Echo Therapeutics, Inc.
GlaxoSmithKline PLC
Johnson& Johnson (Janssen Pharmaceuticals Inc.)

Active Transdermal Drug Delivery Device Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Active Transdermal Drug Delivery Device Market

Active Transdermal Drug Delivery Device Market

The global market for Active Transdermal Drug Delivery Device was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Active Transdermal Drug Delivery Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Active Transdermal Drug Delivery Device.
The Active Transdermal Drug Delivery Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Active Transdermal Drug Delivery Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Active Transdermal Drug Delivery Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Active Transdermal Drug Delivery Device Market Report

Report Metric Details
Report Name Active Transdermal Drug Delivery Device Market
CAGR 5%
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Novartis AG, Noven Pharmaceuticals, Inc., Transdermal Corp., Johnson & Johnson (Janssen Pharmaceuticals Inc.), Mylan N.V., 3M, Actavis, Inc., Bayer AG, Boehringer Ingelheim GmbH, Corium International, Inc., Echo Therapeutics, Inc., GlaxoSmithKline plc
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Active Transdermal Drug Delivery Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Active Transdermal Drug Delivery Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Active Transdermal Drug Delivery Device Market report?

Ans: The main players in the Active Transdermal Drug Delivery Device Market are Novartis AG, Noven Pharmaceuticals, Inc., Transdermal Corp., Johnson & Johnson (Janssen Pharmaceuticals Inc.), Mylan N.V., 3M, Actavis, Inc., Bayer AG, Boehringer Ingelheim GmbH, Corium International, Inc., Echo Therapeutics, Inc., GlaxoSmithKline plc

What are the Application segmentation covered in the Active Transdermal Drug Delivery Device Market report?

Ans: The Applications covered in the Active Transdermal Drug Delivery Device Market report are Clinic, Hospital, Home Use

What are the Type segmentation covered in the Active Transdermal Drug Delivery Device Market report?

Ans: The Types covered in the Active Transdermal Drug Delivery Device Market report are Patches, Gels

Recommended Reports

Drug Delivery Devices

Transdermal Solutions

Novel Therapeutics

1 Active Transdermal Drug Delivery Device Market Overview
1.1 Product Definition
1.2 Active Transdermal Drug Delivery Device by Type
1.2.1 Global Active Transdermal Drug Delivery Device Market Value Comparison by Type (2024 VS 2031)
1.2.2 Patches
1.2.3 Gels
1.3 Active Transdermal Drug Delivery Device by Application
1.3.1 Global Active Transdermal Drug Delivery Device Market Value by Application (2024 VS 2031)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Home Use
1.4 Global Active Transdermal Drug Delivery Device Market Size Estimates and Forecasts
1.4.1 Global Active Transdermal Drug Delivery Device Revenue 2020-2031
1.4.2 Global Active Transdermal Drug Delivery Device Sales 2020-2031
1.4.3 Global Active Transdermal Drug Delivery Device Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Active Transdermal Drug Delivery Device Market Competition by Manufacturers
2.1 Global Active Transdermal Drug Delivery Device Sales Market Share by Manufacturers (2020-2025)
2.2 Global Active Transdermal Drug Delivery Device Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Active Transdermal Drug Delivery Device Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Active Transdermal Drug Delivery Device, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Active Transdermal Drug Delivery Device, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Active Transdermal Drug Delivery Device, Product Type & Application
2.7 Global Key Manufacturers of Active Transdermal Drug Delivery Device, Date of Enter into This Industry
2.8 Global Active Transdermal Drug Delivery Device Market Competitive Situation and Trends
2.8.1 Global Active Transdermal Drug Delivery Device Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Active Transdermal Drug Delivery Device Players Market Share by Revenue
2.8.3 Global Active Transdermal Drug Delivery Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Active Transdermal Drug Delivery Device Market Scenario by Region
3.1 Global Active Transdermal Drug Delivery Device Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Active Transdermal Drug Delivery Device Sales by Region: 2020-2031
3.2.1 Global Active Transdermal Drug Delivery Device Sales by Region: 2020-2025
3.2.2 Global Active Transdermal Drug Delivery Device Sales by Region: 2026-2031
3.3 Global Active Transdermal Drug Delivery Device Revenue by Region: 2020-2031
3.3.1 Global Active Transdermal Drug Delivery Device Revenue by Region: 2020-2025
3.3.2 Global Active Transdermal Drug Delivery Device Revenue by Region: 2026-2031
3.4 North America Active Transdermal Drug Delivery Device Market Facts & Figures by Country
3.4.1 North America Active Transdermal Drug Delivery Device Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Active Transdermal Drug Delivery Device Sales by Country (2020-2031)
3.4.3 North America Active Transdermal Drug Delivery Device Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Active Transdermal Drug Delivery Device Market Facts & Figures by Country
3.5.1 Europe Active Transdermal Drug Delivery Device Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Active Transdermal Drug Delivery Device Sales by Country (2020-2031)
3.5.3 Europe Active Transdermal Drug Delivery Device Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Active Transdermal Drug Delivery Device Market Facts & Figures by Region
3.6.1 Asia Pacific Active Transdermal Drug Delivery Device Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Active Transdermal Drug Delivery Device Sales by Region (2020-2031)
3.6.3 Asia Pacific Active Transdermal Drug Delivery Device Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Active Transdermal Drug Delivery Device Market Facts & Figures by Country
3.7.1 Latin America Active Transdermal Drug Delivery Device Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Active Transdermal Drug Delivery Device Sales by Country (2020-2031)
3.7.3 Latin America Active Transdermal Drug Delivery Device Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Active Transdermal Drug Delivery Device Market Facts & Figures by Country
3.8.1 Middle East and Africa Active Transdermal Drug Delivery Device Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Active Transdermal Drug Delivery Device Sales by Country (2020-2031)
3.8.3 Middle East and Africa Active Transdermal Drug Delivery Device Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Active Transdermal Drug Delivery Device Sales by Type (2020-2031)
4.1.1 Global Active Transdermal Drug Delivery Device Sales by Type (2020-2025)
4.1.2 Global Active Transdermal Drug Delivery Device Sales by Type (2026-2031)
4.1.3 Global Active Transdermal Drug Delivery Device Sales Market Share by Type (2020-2031)
4.2 Global Active Transdermal Drug Delivery Device Revenue by Type (2020-2031)
4.2.1 Global Active Transdermal Drug Delivery Device Revenue by Type (2020-2025)
4.2.2 Global Active Transdermal Drug Delivery Device Revenue by Type (2026-2031)
4.2.3 Global Active Transdermal Drug Delivery Device Revenue Market Share by Type (2020-2031)
4.3 Global Active Transdermal Drug Delivery Device Price by Type (2020-2031)
5 Segment by Application
5.1 Global Active Transdermal Drug Delivery Device Sales by Application (2020-2031)
5.1.1 Global Active Transdermal Drug Delivery Device Sales by Application (2020-2025)
5.1.2 Global Active Transdermal Drug Delivery Device Sales by Application (2026-2031)
5.1.3 Global Active Transdermal Drug Delivery Device Sales Market Share by Application (2020-2031)
5.2 Global Active Transdermal Drug Delivery Device Revenue by Application (2020-2031)
5.2.1 Global Active Transdermal Drug Delivery Device Revenue by Application (2020-2025)
5.2.2 Global Active Transdermal Drug Delivery Device Revenue by Application (2026-2031)
5.2.3 Global Active Transdermal Drug Delivery Device Revenue Market Share by Application (2020-2031)
5.3 Global Active Transdermal Drug Delivery Device Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Novartis AG
6.1.1 Novartis AG Company Information
6.1.2 Novartis AG Description and Business Overview
6.1.3 Novartis AG Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Novartis AG Active Transdermal Drug Delivery Device Product Portfolio
6.1.5 Novartis AG Recent Developments/Updates
6.2 Noven Pharmaceuticals, Inc.
6.2.1 Noven Pharmaceuticals, Inc. Company Information
6.2.2 Noven Pharmaceuticals, Inc. Description and Business Overview
6.2.3 Noven Pharmaceuticals, Inc. Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Noven Pharmaceuticals, Inc. Active Transdermal Drug Delivery Device Product Portfolio
6.2.5 Noven Pharmaceuticals, Inc. Recent Developments/Updates
6.3 Transdermal Corp.
6.3.1 Transdermal Corp. Company Information
6.3.2 Transdermal Corp. Description and Business Overview
6.3.3 Transdermal Corp. Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Transdermal Corp. Active Transdermal Drug Delivery Device Product Portfolio
6.3.5 Transdermal Corp. Recent Developments/Updates
6.4 Johnson & Johnson (Janssen Pharmaceuticals Inc.)
6.4.1 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Company Information
6.4.2 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Description and Business Overview
6.4.3 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Active Transdermal Drug Delivery Device Product Portfolio
6.4.5 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Recent Developments/Updates
6.5 Mylan N.V.
6.5.1 Mylan N.V. Company Information
6.5.2 Mylan N.V. Description and Business Overview
6.5.3 Mylan N.V. Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Mylan N.V. Active Transdermal Drug Delivery Device Product Portfolio
6.5.5 Mylan N.V. Recent Developments/Updates
6.6 3M
6.6.1 3M Company Information
6.6.2 3M Description and Business Overview
6.6.3 3M Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.6.4 3M Active Transdermal Drug Delivery Device Product Portfolio
6.6.5 3M Recent Developments/Updates
6.7 Actavis, Inc.
6.7.1 Actavis, Inc. Company Information
6.7.2 Actavis, Inc. Description and Business Overview
6.7.3 Actavis, Inc. Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Actavis, Inc. Active Transdermal Drug Delivery Device Product Portfolio
6.7.5 Actavis, Inc. Recent Developments/Updates
6.8 Bayer AG
6.8.1 Bayer AG Company Information
6.8.2 Bayer AG Description and Business Overview
6.8.3 Bayer AG Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Bayer AG Active Transdermal Drug Delivery Device Product Portfolio
6.8.5 Bayer AG Recent Developments/Updates
6.9 Boehringer Ingelheim GmbH
6.9.1 Boehringer Ingelheim GmbH Company Information
6.9.2 Boehringer Ingelheim GmbH Description and Business Overview
6.9.3 Boehringer Ingelheim GmbH Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Boehringer Ingelheim GmbH Active Transdermal Drug Delivery Device Product Portfolio
6.9.5 Boehringer Ingelheim GmbH Recent Developments/Updates
6.10 Corium International, Inc.
6.10.1 Corium International, Inc. Company Information
6.10.2 Corium International, Inc. Description and Business Overview
6.10.3 Corium International, Inc. Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Corium International, Inc. Active Transdermal Drug Delivery Device Product Portfolio
6.10.5 Corium International, Inc. Recent Developments/Updates
6.11 Echo Therapeutics, Inc.
6.11.1 Echo Therapeutics, Inc. Company Information
6.11.2 Echo Therapeutics, Inc. Description and Business Overview
6.11.3 Echo Therapeutics, Inc. Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Echo Therapeutics, Inc. Active Transdermal Drug Delivery Device Product Portfolio
6.11.5 Echo Therapeutics, Inc. Recent Developments/Updates
6.12 GlaxoSmithKline plc
6.12.1 GlaxoSmithKline plc Company Information
6.12.2 GlaxoSmithKline plc Description and Business Overview
6.12.3 GlaxoSmithKline plc Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.12.4 GlaxoSmithKline plc Active Transdermal Drug Delivery Device Product Portfolio
6.12.5 GlaxoSmithKline plc Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Active Transdermal Drug Delivery Device Industry Chain Analysis
7.2 Active Transdermal Drug Delivery Device Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Active Transdermal Drug Delivery Device Production Mode & Process Analysis
7.4 Active Transdermal Drug Delivery Device Sales and Marketing
7.4.1 Active Transdermal Drug Delivery Device Sales Channels
7.4.2 Active Transdermal Drug Delivery Device Distributors
7.5 Active Transdermal Drug Delivery Device Customer Analysis
8 Active Transdermal Drug Delivery Device Market Dynamics
8.1 Active Transdermal Drug Delivery Device Industry Trends
8.2 Active Transdermal Drug Delivery Device Market Drivers
8.3 Active Transdermal Drug Delivery Device Market Challenges
8.4 Active Transdermal Drug Delivery Device Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Novartis
Noven Pharmaceuticals, Inc.
Transdermal Corp.
Johnson& Johnson (Janssen Pharmaceuticals Inc.)
Mylan N.V.
3M
Actavis
Bayer
Boehringer Ingelheim GmbH
Corium International, Inc.
Echo Therapeutics, Inc.
GlaxoSmithKline PLC
Johnson& Johnson (Janssen Pharmaceuticals Inc.)
List of Tables
 Table 1. Global Active Transdermal Drug Delivery Device Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Active Transdermal Drug Delivery Device Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Active Transdermal Drug Delivery Device Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Active Transdermal Drug Delivery Device Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Active Transdermal Drug Delivery Device Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Active Transdermal Drug Delivery Device Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Active Transdermal Drug Delivery Device Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Active Transdermal Drug Delivery Device Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Active Transdermal Drug Delivery Device, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Active Transdermal Drug Delivery Device, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Active Transdermal Drug Delivery Device, Product Type & Application
 Table 12. Global Key Manufacturers of Active Transdermal Drug Delivery Device, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Active Transdermal Drug Delivery Device by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Active Transdermal Drug Delivery Device as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Active Transdermal Drug Delivery Device Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Active Transdermal Drug Delivery Device Sales by Region (2020-2025) & (K Units)
 Table 18. Global Active Transdermal Drug Delivery Device Sales Market Share by Region (2020-2025)
 Table 19. Global Active Transdermal Drug Delivery Device Sales by Region (2026-2031) & (K Units)
 Table 20. Global Active Transdermal Drug Delivery Device Sales Market Share by Region (2026-2031)
 Table 21. Global Active Transdermal Drug Delivery Device Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Active Transdermal Drug Delivery Device Revenue Market Share by Region (2020-2025)
 Table 23. Global Active Transdermal Drug Delivery Device Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Active Transdermal Drug Delivery Device Revenue Market Share by Region (2026-2031)
 Table 25. North America Active Transdermal Drug Delivery Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Active Transdermal Drug Delivery Device Sales by Country (2020-2025) & (K Units)
 Table 27. North America Active Transdermal Drug Delivery Device Sales by Country (2026-2031) & (K Units)
 Table 28. North America Active Transdermal Drug Delivery Device Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Active Transdermal Drug Delivery Device Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Active Transdermal Drug Delivery Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Active Transdermal Drug Delivery Device Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Active Transdermal Drug Delivery Device Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Active Transdermal Drug Delivery Device Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Active Transdermal Drug Delivery Device Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Active Transdermal Drug Delivery Device Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Active Transdermal Drug Delivery Device Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Active Transdermal Drug Delivery Device Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Active Transdermal Drug Delivery Device Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Active Transdermal Drug Delivery Device Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Active Transdermal Drug Delivery Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Active Transdermal Drug Delivery Device Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Active Transdermal Drug Delivery Device Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Active Transdermal Drug Delivery Device Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Active Transdermal Drug Delivery Device Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Active Transdermal Drug Delivery Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Active Transdermal Drug Delivery Device Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Active Transdermal Drug Delivery Device Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Active Transdermal Drug Delivery Device Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Active Transdermal Drug Delivery Device Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Active Transdermal Drug Delivery Device Sales (K Units) by Type (2020-2025)
 Table 51. Global Active Transdermal Drug Delivery Device Sales (K Units) by Type (2026-2031)
 Table 52. Global Active Transdermal Drug Delivery Device Sales Market Share by Type (2020-2025)
 Table 53. Global Active Transdermal Drug Delivery Device Sales Market Share by Type (2026-2031)
 Table 54. Global Active Transdermal Drug Delivery Device Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Active Transdermal Drug Delivery Device Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Active Transdermal Drug Delivery Device Revenue Market Share by Type (2020-2025)
 Table 57. Global Active Transdermal Drug Delivery Device Revenue Market Share by Type (2026-2031)
 Table 58. Global Active Transdermal Drug Delivery Device Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Active Transdermal Drug Delivery Device Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Active Transdermal Drug Delivery Device Sales (K Units) by Application (2020-2025)
 Table 61. Global Active Transdermal Drug Delivery Device Sales (K Units) by Application (2026-2031)
 Table 62. Global Active Transdermal Drug Delivery Device Sales Market Share by Application (2020-2025)
 Table 63. Global Active Transdermal Drug Delivery Device Sales Market Share by Application (2026-2031)
 Table 64. Global Active Transdermal Drug Delivery Device Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Active Transdermal Drug Delivery Device Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Active Transdermal Drug Delivery Device Revenue Market Share by Application (2020-2025)
 Table 67. Global Active Transdermal Drug Delivery Device Revenue Market Share by Application (2026-2031)
 Table 68. Global Active Transdermal Drug Delivery Device Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Active Transdermal Drug Delivery Device Price (USD/Unit) by Application (2026-2031)
 Table 70. Novartis AG Company Information
 Table 71. Novartis AG Description and Business Overview
 Table 72. Novartis AG Active Transdermal Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Novartis AG Active Transdermal Drug Delivery Device Product
 Table 74. Novartis AG Recent Developments/Updates
 Table 75. Noven Pharmaceuticals, Inc. Company Information
 Table 76. Noven Pharmaceuticals, Inc. Description and Business Overview
 Table 77. Noven Pharmaceuticals, Inc. Active Transdermal Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Noven Pharmaceuticals, Inc. Active Transdermal Drug Delivery Device Product
 Table 79. Noven Pharmaceuticals, Inc. Recent Developments/Updates
 Table 80. Transdermal Corp. Company Information
 Table 81. Transdermal Corp. Description and Business Overview
 Table 82. Transdermal Corp. Active Transdermal Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Transdermal Corp. Active Transdermal Drug Delivery Device Product
 Table 84. Transdermal Corp. Recent Developments/Updates
 Table 85. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Company Information
 Table 86. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Description and Business Overview
 Table 87. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Active Transdermal Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Active Transdermal Drug Delivery Device Product
 Table 89. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Recent Developments/Updates
 Table 90. Mylan N.V. Company Information
 Table 91. Mylan N.V. Description and Business Overview
 Table 92. Mylan N.V. Active Transdermal Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Mylan N.V. Active Transdermal Drug Delivery Device Product
 Table 94. Mylan N.V. Recent Developments/Updates
 Table 95. 3M Company Information
 Table 96. 3M Description and Business Overview
 Table 97. 3M Active Transdermal Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. 3M Active Transdermal Drug Delivery Device Product
 Table 99. 3M Recent Developments/Updates
 Table 100. Actavis, Inc. Company Information
 Table 101. Actavis, Inc. Description and Business Overview
 Table 102. Actavis, Inc. Active Transdermal Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. Actavis, Inc. Active Transdermal Drug Delivery Device Product
 Table 104. Actavis, Inc. Recent Developments/Updates
 Table 105. Bayer AG Company Information
 Table 106. Bayer AG Description and Business Overview
 Table 107. Bayer AG Active Transdermal Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. Bayer AG Active Transdermal Drug Delivery Device Product
 Table 109. Bayer AG Recent Developments/Updates
 Table 110. Boehringer Ingelheim GmbH Company Information
 Table 111. Boehringer Ingelheim GmbH Description and Business Overview
 Table 112. Boehringer Ingelheim GmbH Active Transdermal Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 113. Boehringer Ingelheim GmbH Active Transdermal Drug Delivery Device Product
 Table 114. Boehringer Ingelheim GmbH Recent Developments/Updates
 Table 115. Corium International, Inc. Company Information
 Table 116. Corium International, Inc. Description and Business Overview
 Table 117. Corium International, Inc. Active Transdermal Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 118. Corium International, Inc. Active Transdermal Drug Delivery Device Product
 Table 119. Corium International, Inc. Recent Developments/Updates
 Table 120. Echo Therapeutics, Inc. Company Information
 Table 121. Echo Therapeutics, Inc. Description and Business Overview
 Table 122. Echo Therapeutics, Inc. Active Transdermal Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 123. Echo Therapeutics, Inc. Active Transdermal Drug Delivery Device Product
 Table 124. Echo Therapeutics, Inc. Recent Developments/Updates
 Table 125. GlaxoSmithKline plc Company Information
 Table 126. GlaxoSmithKline plc Description and Business Overview
 Table 127. GlaxoSmithKline plc Active Transdermal Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 128. GlaxoSmithKline plc Active Transdermal Drug Delivery Device Product
 Table 129. GlaxoSmithKline plc Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Active Transdermal Drug Delivery Device Distributors List
 Table 133. Active Transdermal Drug Delivery Device Customers List
 Table 134. Active Transdermal Drug Delivery Device Market Trends
 Table 135. Active Transdermal Drug Delivery Device Market Drivers
 Table 136. Active Transdermal Drug Delivery Device Market Challenges
 Table 137. Active Transdermal Drug Delivery Device Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Active Transdermal Drug Delivery Device
 Figure 2. Global Active Transdermal Drug Delivery Device Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Active Transdermal Drug Delivery Device Market Share by Type: 2024 & 2031
 Figure 4. Patches Product Picture
 Figure 5. Gels Product Picture
 Figure 6. Global Active Transdermal Drug Delivery Device Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Active Transdermal Drug Delivery Device Market Share by Application: 2024 & 2031
 Figure 8. Clinic
 Figure 9. Hospital
 Figure 10. Home Use
 Figure 11. Global Active Transdermal Drug Delivery Device Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Active Transdermal Drug Delivery Device Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Active Transdermal Drug Delivery Device Sales (2020-2031) & (K Units)
 Figure 14. Global Active Transdermal Drug Delivery Device Average Price (USD/Unit) & (2020-2031)
 Figure 15. Active Transdermal Drug Delivery Device Report Years Considered
 Figure 16. Active Transdermal Drug Delivery Device Sales Share by Manufacturers in 2024
 Figure 17. Global Active Transdermal Drug Delivery Device Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Active Transdermal Drug Delivery Device Players: Market Share by Revenue in Active Transdermal Drug Delivery Device in 2024
 Figure 19. Active Transdermal Drug Delivery Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Active Transdermal Drug Delivery Device Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Active Transdermal Drug Delivery Device Sales Market Share by Country (2020-2031)
 Figure 22. North America Active Transdermal Drug Delivery Device Revenue Market Share by Country (2020-2031)
 Figure 23. U.S. Active Transdermal Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Active Transdermal Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Active Transdermal Drug Delivery Device Sales Market Share by Country (2020-2031)
 Figure 26. Europe Active Transdermal Drug Delivery Device Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Active Transdermal Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Active Transdermal Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Active Transdermal Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Active Transdermal Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Active Transdermal Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Active Transdermal Drug Delivery Device Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Active Transdermal Drug Delivery Device Revenue Market Share by Region (2020-2031)
 Figure 34. China Active Transdermal Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Active Transdermal Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Active Transdermal Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Active Transdermal Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Active Transdermal Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Taiwan Active Transdermal Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Active Transdermal Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Active Transdermal Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Active Transdermal Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Philippines Active Transdermal Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Active Transdermal Drug Delivery Device Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Active Transdermal Drug Delivery Device Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Active Transdermal Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Active Transdermal Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Active Transdermal Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Active Transdermal Drug Delivery Device Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Active Transdermal Drug Delivery Device Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Active Transdermal Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Active Transdermal Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Active Transdermal Drug Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Active Transdermal Drug Delivery Device by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Active Transdermal Drug Delivery Device by Type (2020-2031)
 Figure 56. Global Active Transdermal Drug Delivery Device Price (USD/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Active Transdermal Drug Delivery Device by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Active Transdermal Drug Delivery Device by Application (2020-2031)
 Figure 59. Global Active Transdermal Drug Delivery Device Price (USD/Unit) by Application (2020-2031)
 Figure 60. Active Transdermal Drug Delivery Device Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Passive Transdermal Drug Delivery Market Research Report 2024
Drug Transdermal Diffusion Apparatus Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Drug Transdermal Diffusion Tester Market Research Report 2024
Microneedle Transdermal Drug Delivery System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pulmonary Drug Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Advanced Targeted Drug Delivery Market Research Report 2025
Drug Delivery Technologies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Needle Free Drug Delivery Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Aerosol Drug Delivery Devices Market Research Report 2025
Wearable Drug Delivery Systems Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pain Therapy Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Electronic Drug Delivery Systems Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Vaccine Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Drug Delivery System Development Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Alternative Drug Delivery Systems Market Research Report 2024
Global Dermatological OTC Drugs Market Research Report 2024
Diabetes Therapy Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Injectable Drug Delivery System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Human Interventional Treatment Device Market Research Report 2025
Prescription Dermatology Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions